You are in our Global Site

Change location

Our website does not support this browser  

World Diabetes Congress 2013

The International Diabetes Federation will hold the next World Diabetes Congress at Melbourne, Australia from 2 to 6 December 2013.


The World Diabetes Congress presents an enormous opportunity to share the most recent evidence and best practice to support improvements in diabetes care, treatment and prevention.

Nestlé is committed to using its capabilities and expertise to tackle health challenges including diabetes and other non-communicable diseases. By working with partners like the International Diabetes Federation, we believe we can build awareness and promote healthy lifestyles through balanced nutrition and physical activity.

The Nestlé Nutrition Institute will sponsor a satellite symposium on Thursday 5th December.






Nestlé Health Science  is engaged in elevating and expanding the role of nutrition in the healthcare systems approach to acute and chronic medical conditions, harnessing the developing world of nutritional science. Metabolic Health – with a portfolio addressing obesity and diabetic neuropathy – is one of six areas of focus, including Ageing Medical Care, Critical Care and Surgery, Paediatric Medical Care, Gastrointestinal Health and Brain Health. Optifast® and Metanx® are part of Nestlé Health Science’s band portfolio.



Optifast® VLCD™ products are low glycemic index, making them suitable for managing obesity in people with diabetes. The Optifast® VLCD™ programme is clinically proven and offers a range of convenient meal replacements.  


Related information

Read more about Nestlé’s partnerships

Follow Nestlé Creating Shared Value news on Twitter @nestlecsv